Cost-effectiveness of tapentadol prolonged release compared with oxycodone controlled release in the UK in patients with severe non-malignant chronic pain who failed 1st line treatment with morphine
Ikenberg, Robert, Hertel, Nadine, Andrew Moore, R., Obradovic, Marko, Baxter, Garth, Conway, Pete, Liedgens, HiltrudТом:
15
Мова:
english
Журнал:
Journal of Medical Economics
DOI:
10.3111/13696998.2012.670174
Date:
August, 2012
Файл:
PDF, 488 KB
english, 2012
File converter
Більше результатів пошуку
More benefits 
